查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602334

API 中间体市场：按类型、原材料、应用和最终用户划分 - 全球预测 2025-2030

API Intermediates Market by Type (Bulk Drug Intermediates, Chemical Intermediates), Raw Material (Carbonyl, Chloro, Nitrile), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

API中间体市场2023年估值为1786.3亿美元，预计到2024年将达到1926.5亿美元，复合年增长率为7.85%，到2030年将达到3032.3亿美元。

API中间体是製药业的重要成分，是用于合成活性药物成分（API）的化合物或药物。它是药品製造多步骤过程中的关键步骤，提供原料或稀释剂来源与最终活性成分之间的关联。对 API 中间体的需求源于它们在优化最终药物的功效、安全性和稳定性、促进药物进步和大规模生产方面的作用。这些中间体在从非处方药到处方药的广泛药物类别中具有应用，并且是新疗法和学名药的基础。最终用途范围主要针对以药物开发和生产为重点的製药公司和研究机构。

主要市场统计
基准年[2023] 1786.3亿美元
预测年份 [2024] 1926.5亿美元
预测年份 [2030] 3032.3亿美元
复合年增长率（%） 7.85%

API中间体市场受到学名药需求增加、生物製药技术进步以及全球需要新治疗方法的慢性疾病数量增加等因素的显着影响。持续的技术创新正在推动需求，尤其是需要专门中间体的复杂原料药，商机比比皆是。公司可以透过投资人工智慧和机器学习等最尖端科技来优化流程，并加强与生物技术公司的合作以促进研发进步，从而利用机会。然而，市场成长面临限制，例如严格的监管要求会延长核准时间并增加开发成本。此外，原物料价格波动也是一个持续的挑战。

为了缓解这些挑战，企业应该专注于绿色化学等永续实践。技术创新部分包括提高生产流程的可扩展性以及利用CRISPR和其他基因技术开发新的中间体。开放这个竞争激烈但前景广阔的市场需要策略远见，特别注重透过策略伙伴关係关係扩大产品组合，并做出进入新兴市场以挖掘开拓潜力的决策。

市场动态：揭示快速发展的 API 中间体市场的关键市场洞察

API 中间体市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病流行和对学名药的需求
    • 政府促进生物製药生产活动的倡议
    • 越来越多地采用罕见疾病和治疗罕见疾病的特殊原料药
  • 市场限制因素
    • API 中间体的复杂采购与智慧财产权问题
  • 市场机会
    • API中间体的合成与加工研究进展
    • 专门从事原料药製造的受託製造厂商的兴起
  • 市场问题
    • API 中间体安全与品质的监管复杂性

波特五力：驾驭 API 中间体市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解API中间体市场的外部影响

外部宏观环境因素在塑造 API 中间体市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解API中间体市场的竞争格局

API 中间体市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：API 中间体市场供应商绩效评估

FPNV 定位矩阵是评估 API 中间体市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製 API 中间体市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，API 中间体市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病的流行和对学名药的需求
      • 政府促进生物製药生产活动的倡议
      • 更多地采用专门的 API 来治疗罕见和不治之症
    • 抑制因素
      • 取得 API 中间体的复杂性和智慧财产权问题
    • 机会
      • API中间体的合成与加工研究进展
      • 专门从事 API 製造的契约製造组织的兴起
    • 任务
      • API 中间体安全与品质的监管复杂性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 API 中间体市场：依类型

  • 介绍
  • 原料药中间体
  • 化学中间体

第七章原料药中间体市场：依原料分类

  • 介绍
  • 羰
  • 库洛洛
  • 丁腈橡胶
  • 硝基

第八章原料药中间体市场：依应用分类

  • 介绍
  • 止痛药
  • 抗感染
  • 抗癌药
  • 抗糖尿病药
  • 心血管药物

第 9 章 API 中间体市场：依最终使用者划分

  • 介绍
  • 生物技术和製药公司
  • 首席行销长
  • 研究所

第十章 美洲原料药中间体市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太原料药中间体市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东及非洲原料药中间体市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Sigachi Industries 进军 API 业务并收购 Trimax Bio Sciences 多数股权
    • 勃林格殷格翰与德国总理奥拉夫舒尔茨举行耗资 2.85 亿欧元的研发中心奠基仪式
    • FLAMMA未来三年投资2亿美元
  • 战略分析和建议

公司名单

  • Aarti Pharmalabs Limited
  • Actylis
  • Alzchem Group
  • API Corporation by UBE Corp.
  • Atul Ltd.
  • Aurobindo Pharma
  • BASF SE
  • Cambrex Corp.
  • Cation Pharma
  • Divi's Laboratories Limited
  • Dr. Reddy's Laboratories Ltd.
  • Espee Group
  • Evonik Industries AG
  • Flamma Group
  • Hikal Ltd.
  • Kaneka Corporation
  • Levachem Company Ltd.
  • Lupin Ltd.
  • Nectar Lifesciences Ltd.
  • Noah Chemicals
  • Pfizer Inc.
  • Proviron Holding NV
  • Sandoo Pharmaceuticals and Chemicals Co., Ltd.
  • Sandoz International GmbH by Novartis AG
  • Sanofi
  • Sarex
  • Shree Ganesh Remedies Ltd.
  • Sumitomo Chemical Co., Ltd.
  • Vertellus
  • ZCL Chemicals Ltd. by Advent International
Product Code: MRR-CF699CF4142A

The API Intermediates Market was valued at USD 178.63 billion in 2023, expected to reach USD 192.65 billion in 2024, and is projected to grow at a CAGR of 7.85%, to USD 303.23 billion by 2030.

API intermediates, essential components in the pharmaceutical industry, are compounds or agents used in the synthesis of active pharmaceutical ingredients (APIs). They represent a critical step in the multi-stage process of drug manufacturing, bridging raw materials and diluted sources with the final active ingredients. The necessity of API intermediates arises from their role in optimizing the efficacy, safety, and stability of final pharmaceutical products, thus facilitating the advancement and mass production of medications. These intermediates find applications across a wide range of medication categories-spanning from over-the-counter drugs to prescription medications-serving as the foundation for novel therapies and generic products. The end-use scope primarily targets pharmaceutical companies and research institutes prioritizing drug development and production.

KEY MARKET STATISTICS
Base Year [2023] USD 178.63 billion
Estimated Year [2024] USD 192.65 billion
Forecast Year [2030] USD 303.23 billion
CAGR (%) 7.85%

The API intermediates market is significantly influenced by factors such as increased demand for generic drugs, advancements in biopharmaceutical technologies, and the rise of chronic diseases worldwide necessitating novel therapies. Opportunities abound as continuous innovation drives demand, particularly in complex APIs requiring specialized intermediates. Companies can tap into opportunities by investing in cutting-edge technologies like AI and machine learning for process optimization and increasing collaborations with biotech firms for R&D advancements. However, market growth faces limitations such as stringent regulatory requirements, which elongate approval times and raise development costs. Additionally, the volatility in raw material prices poses a consistent challenge.

To mitigate challenges, businesses should focus on sustainable practices such as green chemistry, which reduces environmental impact and aligns with regulatory shifts favoring eco-friendly processes. Areas for innovation include enhancing the scalability of production processes and leveraging CRISPR and other genetic technologies for the development of novel intermediates. Navigating this competitive, yet promising market requires strategic foresight, with a particular emphasis on expanding portfolios through strategic partnerships and determining market entry in emerging economies to harness under-tapped potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving API Intermediates Market

The API Intermediates Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic diseases and need for generic drugs
    • Government initiatives promoting biopharmaceutical manufacturing activities
    • Increased adoption of specialty APIs for rare and orphan disease treatment
  • Market Restraints
    • Complicated sourcing of API intermediates and intellectual property concerns
  • Market Opportunities
    • Advancements in synthesizing and processing of API intermediates
    • Rise of contract manufacturing organizations specializing in API production
  • Market Challenges
    • Regulatory complexity concerning the safety and quality of API intemediates

Porter's Five Forces: A Strategic Tool for Navigating the API Intermediates Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the API Intermediates Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the API Intermediates Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the API Intermediates Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the API Intermediates Market

A detailed market share analysis in the API Intermediates Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the API Intermediates Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the API Intermediates Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the API Intermediates Market

A strategic analysis of the API Intermediates Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the API Intermediates Market, highlighting leading vendors and their innovative profiles. These include Aarti Pharmalabs Limited, Actylis, Alzchem Group, API Corporation by UBE Corp., Atul Ltd., Aurobindo Pharma, BASF SE, Cambrex Corp., Cation Pharma, Divi's Laboratories Limited, Dr. Reddy's Laboratories Ltd., Espee Group, Evonik Industries AG, Flamma Group, Hikal Ltd., Kaneka Corporation, Levachem Company Ltd., Lupin Ltd., Nectar Lifesciences Ltd., Noah Chemicals, Pfizer Inc., Proviron Holding NV, Sandoo Pharmaceuticals and Chemicals Co., Ltd., Sandoz International GmbH by Novartis AG, Sanofi, Sarex, Shree Ganesh Remedies Ltd., Sumitomo Chemical Co., Ltd., Vertellus, and ZCL Chemicals Ltd. by Advent International.

Market Segmentation & Coverage

This research report categorizes the API Intermediates Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Bulk Drug Intermediates and Chemical Intermediates.
  • Based on Raw Material, market is studied across Carbonyl, Chloro, Nitrile, and Nitro.
  • Based on Application, market is studied across Analgesics, Anti-Infective Drugs, Anticancer Drugs, Antidiabetic Drugs, and Cardiovascular Drugs.
  • Based on End User, market is studied across Biotech & Pharmaceutical Companies, CMO, and Research Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and need for generic drugs
      • 5.1.1.2. Government initiatives promoting biopharmaceutical manufacturing activities
      • 5.1.1.3. Increased adoption of specialty APIs for rare and orphan disease treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Complicated sourcing of API intermediates and intellectual property concerns
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in synthesizing and processing of API intermediates
      • 5.1.3.2. Rise of contract manufacturing organizations specializing in API production
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory complexity concerning the safety and quality of API intemediates
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. API Intermediates Market, by Type

  • 6.1. Introduction
  • 6.2. Bulk Drug Intermediates
  • 6.3. Chemical Intermediates

7. API Intermediates Market, by Raw Material

  • 7.1. Introduction
  • 7.2. Carbonyl
  • 7.3. Chloro
  • 7.4. Nitrile
  • 7.5. Nitro

8. API Intermediates Market, by Application

  • 8.1. Introduction
  • 8.2. Analgesics
  • 8.3. Anti-Infective Drugs
  • 8.4. Anticancer Drugs
  • 8.5. Antidiabetic Drugs
  • 8.6. Cardiovascular Drugs

9. API Intermediates Market, by End User

  • 9.1. Introduction
  • 9.2. Biotech & Pharmaceutical Companies
  • 9.3. CMO
  • 9.4. Research Laboratories

10. Americas API Intermediates Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific API Intermediates Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa API Intermediates Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Sigachi Industries Forays into API business, Acquires Majority Stake in Trimax Bio Sciences
    • 13.3.2. Boehringer Ingelheim and German Chancellor Olaf Scholz Lay The Foundation Stone for 285 million EUR Innovation Center
    • 13.3.3. FLAMMA to Invest USD 200 Million Over the Next 3 Years
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aarti Pharmalabs Limited
  • 2. Actylis
  • 3. Alzchem Group
  • 4. API Corporation by UBE Corp.
  • 5. Atul Ltd.
  • 6. Aurobindo Pharma
  • 7. BASF SE
  • 8. Cambrex Corp.
  • 9. Cation Pharma
  • 10. Divi's Laboratories Limited
  • 11. Dr. Reddy's Laboratories Ltd.
  • 12. Espee Group
  • 13. Evonik Industries AG
  • 14. Flamma Group
  • 15. Hikal Ltd.
  • 16. Kaneka Corporation
  • 17. Levachem Company Ltd.
  • 18. Lupin Ltd.
  • 19. Nectar Lifesciences Ltd.
  • 20. Noah Chemicals
  • 21. Pfizer Inc.
  • 22. Proviron Holding NV
  • 23. Sandoo Pharmaceuticals and Chemicals Co., Ltd.
  • 24. Sandoz International GmbH by Novartis AG
  • 25. Sanofi
  • 26. Sarex
  • 27. Shree Ganesh Remedies Ltd.
  • 28. Sumitomo Chemical Co., Ltd.
  • 29. Vertellus
  • 30. ZCL Chemicals Ltd. by Advent International

LIST OF FIGURES

  • FIGURE 1. API INTERMEDIATES MARKET RESEARCH PROCESS
  • FIGURE 2. API INTERMEDIATES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL API INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL API INTERMEDIATES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL API INTERMEDIATES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL API INTERMEDIATES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL API INTERMEDIATES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL API INTERMEDIATES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES API INTERMEDIATES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES API INTERMEDIATES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. API INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. API INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. API INTERMEDIATES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL API INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL API INTERMEDIATES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. API INTERMEDIATES MARKET DYNAMICS
  • TABLE 7. GLOBAL API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL API INTERMEDIATES MARKET SIZE, BY BULK DRUG INTERMEDIATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL API INTERMEDIATES MARKET SIZE, BY CHEMICAL INTERMEDIATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL API INTERMEDIATES MARKET SIZE, BY CARBONYL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL API INTERMEDIATES MARKET SIZE, BY CHLORO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL API INTERMEDIATES MARKET SIZE, BY NITRILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL API INTERMEDIATES MARKET SIZE, BY NITRO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL API INTERMEDIATES MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL API INTERMEDIATES MARKET SIZE, BY ANTI-INFECTIVE DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL API INTERMEDIATES MARKET SIZE, BY ANTICANCER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL API INTERMEDIATES MARKET SIZE, BY ANTIDIABETIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL API INTERMEDIATES MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL API INTERMEDIATES MARKET SIZE, BY BIOTECH & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL API INTERMEDIATES MARKET SIZE, BY CMO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL API INTERMEDIATES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES API INTERMEDIATES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. API INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. API INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2023